Saturday, August 18, 2018
 
 
News: Page (1) of 1 - 09/08/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
FDA advisers recommend approving anticlotting drug
FDA advisers recommend approving anticlotting drug from Johnson & Johnson and partner Bayer
By The Associated Press

TRENTON, N.J. (AP) ' Outside advisers to the Food and Drug Administration have voted to recommend that the agency approve a new anticlotting drug developed by Johnson & Johnson and partner Bayer Healthcare.

That's despite a very negative review by FDA staff of the drug, Xarelto, released two days ago.

Nine panel members voted to recommend approval, two voted against and one person abstained. The FDA is to make a final decision soon.



The recommendation, after a daylong hearing, is to allow sales of the drug for preventing strokes in patients with a common irregular heartbeat known as atrial fibrillation.

Xarelto, known chemically as rivaroxaban, has been seen as a future blockbuster drug.


Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines